Sasipong, N. (2019). Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment.
Chicago-Zitierstil (17. Ausg.)Sasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. Heidelberg, 2019.
MLA-Zitierstil (9. Ausg.)Sasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.